LeMaitre Vascular, Inc. (LMAT)
101.53
+0.70
(+0.69%)
USD |
NASDAQ |
May 19, 16:00
101.53
0.00 (0.00%)
After-Hours: 20:00
LeMaitre Vascular Research and Development Expense (Quarterly) : 4.06M for March 31, 2026
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Globus Medical, Inc. | 36.51M |
| Alphatec Holdings, Inc. | 17.56M |
| Apyx Medical Corp. | 0.765M |
| Integer Holdings Corp. | 16.09M |
| Intuitive Surgical, Inc. | 361.60M |